CONTRACT MANUFACTURING
Gemini Pharmaceuticals
Gemini Pharmaceuticals has produced tablets, capsules, and OTC pharmaceuticals from Commack, New York for over 30 years. The company produces 13 billion dosage units per year and packages over 150,000 bottles per shift. They report FDA registration, Health Canada site licensing, TGA (Australia) listing, and NSF International certification, though NSF could not be confirmed through NSF's public GMP directory as of March 2026. Gemini was the first manufacturer to earn RIBUS Certified Contract Manufacturer status for clean label products. They recently received approval for a $25 million expansion supported by Suffolk County IDA incentives. This expansion includes a new probiotic supplement facility at 81 Modular Avenue. Their 300,000 unit minimum order signals they serve mid-to-large brands, not startups. The ISO 17025 accredited in-house laboratory handles identity testing, potency analysis, and stability studies.
Commack, New York
Directory Listing · Records Reviewed
Public records and independent sources have been reviewed.
What this means →- MOQMOQ (Minimum Order Quantity)The smallest production run a manufacturer will accept for an order.
- 300,000 units
- LEAD TIMELead TimeThe time from order placement to finished product delivery.
- Not publicly disclosed
§1Editorial assessment
Gemini Pharmaceuticals has produced tablets, capsules, and OTC pharmaceuticals from Commack, New York for over 30 years. The company produces 13 billion dosage units per year and packages over 150,000 bottles per shift. They report FDA registration, Health Canada site licensing, TGA (Australia) listing, and NSF International certification, though NSF could not be confirmed through NSF's public GMP directory as of March 2026. Gemini was the first manufacturer to earn RIBUS Certified Contract Manufacturer status for clean label products. They recently received approval for a $25 million expansion supported by Suffolk County IDA incentives. This expansion includes a new probiotic supplement facility at 81 Modular Avenue. Their 300,000 unit minimum order signals they serve mid-to-large brands, not startups. The ISO 17025 accredited in-house laboratory handles identity testing, potency analysis, and stability studies.
§2Six-gate readout
Six gates we apply before any name appears in the directory. Each gate is auto-derived from public evidence on this profile.
§3Inspection history
§4Certifications
0 of 8 certifications independently confirmed. What this means
§5Capability matrix
- PRODUCT TYPES
- Tablets · Capsules · OTC Pharmaceuticals
- CAPABILITIES
- Contract Manufacturing · Private Label · In-House Testing Lab · Clean Label Products · OTC Pharmaceuticals
- DOSAGE FORMS
- capsules · tablets
§6Sources
- Gemini Pharmaceuticals - Official Website(2026-03-12)
- Suffolk County IDA Expansion ($25M)(2026-03-12)
- Non-GMO Project Verification(2026-03-12)
- RIBUS Certification(2026-03-12)
Dietary supplement manufacturers must comply with 21 CFR Part 111 (Current Good Manufacturing Practice for dietary supplements). This includes requirements for personnel, facilities, equipment, production, laboratory operations, and record-keeping.
What We Couldn't Verify
- High MOQ (300,000 units) makes this manufacturer unsuitable for startups
- Lead times not publicly disclosed
- On-site facility inspection was not conducted
Last reviewed: March 12, 2026
Disclosures
- No material connection exists between Inventory Ready and this manufacturer
Our Evaluation Method
Every manufacturer assessment follows six principles:
- Evidence: Claims backed by documentation, not marketing copy
- Freshness: Information reviewed and dated within the last 12 months
- Provenance: Sources cited for every key claim
- Challenge: Inconsistencies flagged, not hidden
- Disclosure: Material connections stated directly on affected listings
- Abstention: When we can't assess, we say so explicitly
Interested in Gemini Pharmaceuticals?
Tell us about your project and we'll help you determine if this manufacturer is a good fit.